Bayer downgraded to Market Perform from Outperform at Bernstein

Bernstein downgraded Bayer to Market Perform from Outperform with a price target of EUR 27, down from EUR 50. The firm says its expectation that corporate action would unlock a valuation discount has not played out. The analyst still believes a break up is likely “but not on the timescale that investors are looking at.”